Musculoskeletal Injury — Predictive Models for Spine and Lower Extremity Injury After Discharge From Rehab
Citation(s)
Bahr R Why screening tests to predict injury do not work-and probably never will…: a critical review. Br J Sports Med. 2016 Jul;50(13):776-80. doi: 10.1136/bjsports-2016-096256. Epub 2016 Apr 19. Review.
Bonazza NA, Smuin D, Onks CA, Silvis ML, Dhawan A Reliability, Validity, and Injury Predictive Value of the Functional Movement Screen: A Systematic Review and Meta-analysis. Am J Sports Med. 2017 Mar;45(3):725-732. doi: 10.1177/0363546516641937. Epub 20
Knapik JJ, Graham B, Cobbs J, Thompson D, Steelman R, Jones BH A prospective investigation of injury incidence and injury risk factors among Army recruits in military police training. BMC Musculoskelet Disord. 2013 Jan 17;14:32. doi: 10.1186/1471-2474-14-32.
Larsson H, Broman L, Harms-Ringdahl K Individual risk factors associated with premature discharge from military service. Mil Med. 2009 Jan;174(1):9-20.
Lehr ME, Plisky PJ, Butler RJ, Fink ML, Kiesel KB, Underwood FB Field-expedient screening and injury risk algorithm categories as predictors of noncontact lower extremity injury. Scand J Med Sci Sports. 2013 Aug;23(4):e225-32. doi: 10.1111/sms.12062. Epub 2013 Mar 20.
Lincoln AE, Smith GS, Amoroso PJ, Bell NS The natural history and risk factors of musculoskeletal conditions resulting in disability among US Army personnel. Work. 2002;18(2):99-113.
Parkkari J, Kujala UM, Kannus P Is it possible to prevent sports injuries? Review of controlled clinical trials and recommendations for future work. Sports Med. 2001;31(14):985-95. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
